Kenvue reports first quarter 2025 results
“In Q1, our teams executed our plans while continuing to navigate an evolving macro and consumer environment,” said Thibaut Mongon, Chief Executive Officer. “We are committed and focused on activating our brands while staying agile and flexible to accelerate sustainable profitable growth.”
Media contacts
Working members of the media, please contact the Kenvue media relations team with inquiries.
- Please put ON DEADLINE in the subject of the email and be as specific as possible with your request.
- Requests received after business hours will be responded to as soon as possible.
Resources for members of the media
Thank you for your interest in learning more about our company.
We’ve made the below resources available to you but also want to make sure you can find what you’re looking for. Please contact the Kenvue media relations team if you have any questions.
We’ve made the below resources available to you but also want to make sure you can find what you’re looking for. Please contact the Kenvue media relations team if you have any questions.
$15.5 bn+
Net sales for 2024
As the world’s largest pure-play consumer health company by revenue.
135+
Year history
Across our brands — redefining what care really means.
~1.2bn
Global consumers
The number of lives we touch around the world.
Latest news
Find out what’s new in our world of care.
Kenvue announces CEO transition and actions to unlock shareholder value
• Appoints current Kenvue Director and proven CPG and technology company leader, Kirk Perry, as Interim CEO, effective immediately
• Announces ongoing review of strategic alternatives
• Reports select preliminary second quarter 2025 financial results
• Announces ongoing review of strategic alternatives
• Reports select preliminary second quarter 2025 financial results
Kenvue releases second annual Healthy Lives Mission report
- Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio
Kenvue announces leadership transition in Asia Pacific region
- Anindya Dasgupta, 30-year consumer products industry veteran to join Kenvue, appointed Group President, Asia Pacific, effective July 14, 2025
Tylenol® expands expertise to proactive joint care with launch into the supplement category
From relief to routine: Proactive Support from the Makers of Tylenol® delivers clinically backed ingredients that provide effective, drug-free joint support.†
The National Women’s Soccer League and Tylenol® announce multi-year partnership
Tylenol®, the #1 doctor-recommended pain relief brand, becomes official pain reliever of NWSL
Everyday care in action: Thousands of Kenvue employees come together across 21 markets to help advance healthier communities
- Kenvuers contribute 5,000+ hours of volunteer time to local causes along with building 22,000+ hygiene kits for underserved communities
- Hygiene kits to feature 110,000+ donated products from iconic brands Neutrogena®, Listerine®, OGX®, Johnson’s® Baby and more
- Hygiene kits to feature 110,000+ donated products from iconic brands Neutrogena®, Listerine®, OGX®, Johnson’s® Baby and more
Our commitments
At Kenvue, our impact is made through moments of care—the daily care we offer consumers through our portfolio of iconic brands and the actions we take to protect our environment. Our approach to sustainability is designed to effectively govern and manage impacts while also enabling us to identify opportunities that accelerate innovation, profitable growth and drive business value for all our stakeholders. We call it our Healthy Lives Mission. It’s how we show everyday care in action.
37%
reduction in Emissionsas of 2024
~72%
of Kenvue operations run on renewable electricityas of 2024
21.4%
reduction in use of virgin plasticas of 2024
~56M+
donated in product and monetary aid worldwideas of 2024